IP Library Granted Patent US 9,725,734
Granted Patent B2
US 9,725,734 · App. 14/691,780 · Granted Aug 8, 2017

Thionin-D4E1 chimeric protein protects plants against bacterial infections

Inventors: Eddie W Stover (Fort Pierce, FL); Goutam Gupta (Santa Fe, NM); Guixia Hao (Fort Pierce, FL)
Assignees: The United States of America, as represented by the Secretary of Agriculture; Los Alamos National Security, LLC
C12N15/8281C07K7/08C07K14/415C07K2319/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,725,734
App. No.
14/691,780
Granted
Aug 8, 2017
Kind
B2
Abstract

The generation of a chimeric protein containing a first domain encoding either a pro-thionon or thionin, a second domain encoding D4E1 or pro-D4E1, and a third domain encoding a peptide linker located between the first domain and second domain is described. Either the first domain or the second domain is located at the amino terminal of the chimeric protein and the other domain (second domain or first domain, respectively) is located at the carboxyl terminal. The chimeric protein has antibacterial activity. Genetically altered plants and their progeny expressing a polynucleotide encoding the chimeric protein resist diseases caused by bacteria.

Claims (18)

1. A genetically altered plant, a part or progeny thereof comprising a promoter operably linked to a polynucleotide encoding a chimeric protein comprising SEQ ID NO: 8 or SEQ ID NO: 18, wherein said genetically altered plant or parts thereof and its progeny produce said chimeric protein, and wherein said genetically altered plant, part or progeny thereof is more resistant to Xanthomonas citri ssp. citri compared to a wild-type plant's resistance to X. citri ssp. citri.

2. A method for constructing a genetically altered plant or part thereof having increased resistance to Xanthomonas citri ssp. citri compared to a non-genetically altered plant or part thereof, the method comprising:

(i) introducing a polynucleotide encoding a chimeric protein into a plant or part thereof to produce a genetically altered plant or part thereof, wherein said chimeric protein comprising a first domain, a second domain, and a third domain, wherein said first domain comprises optimized thionin or optimized pro-thionin, said second domain comprises D4E1 or pro-D4EI, and said third domain comprises a peptide linker; wherein said peptide linker separates said first domain from said second domain such that said first domain and said second domain can each fold into its appropriate three-dimensional shape and retains its activity, and wherein said peptide linker ranges in length between three amino acids and approximately forty-four amino acids;

(ii) selecting a genetically altered plant or part thereof that expresses said chimeric protein, wherein said expressed chimeric protein has anti-bacterial activity against X. citri ssp. citri ; wherein said genetically altered plant or part thereof has increased resistance to X. citri ssp. citri compared to the resistance to X. citri ssp. citri of said non-genetically altered plant or part thereof; and wherein said optimized thionin comprises the amino acid sequence of SEP ID NO: 14, said optimized pro-thionin comprises the amino acid sequence of SEP ID NO: 6, said D4E1 comprises the amino acid sequence of SEP ID NO: 2, and said pro-D4EI comprises the amino acid of SEP ID NO: 62.

3. The method of claim 2 , wherein said introducing said polynucleotide encoding said chimeric protein occurs via introgression or transforming said plant with an expression vector comprising said polynucleotide operably linked to a promoter.

4. The method of claim 2 , wherein said optimized thionin or said optimized pro-thionin is located at the amino terminus of said chimeric protein; and wherein said D4E1 is located at the carboxyl terminus of said chimeric protein.

5. The method of claim 2 , wherein said D4E1 or said pro-D4E1 is located at the amino terminus of said chimeric protein; and wherein said optimized thionin is located at the carboxyl terminus of said chimeric protein.

6. A method of enhancing a wild-type plant's resistance to canker comprising transforming a cell from said wild-type plant with a polynucleotide encoding a chimeric protein to generate a transformed plant cell; and growing said transformed plant cell to generate a genetically altered plant; wherein said chimeric protein comprises a first domain, a second domain, and a third domain; wherein said first domain comprises optimized thionin or optimized pro-thionin, said second domain comprises D4E1 or pro-D4E1, and said third domain comprises a peptide linker; wherein said peptide linker separates said first domain from said second domain such that said first domain and said second domain can each fold into its appropriate three-dimensional shape and retains its activity; wherein said peptide linker is ranges in length between three amino acids and approximately forty-four amino acids; wherein said genetically altered plant or part thereof produces said chimeric protein; and wherein said chimeric protein kills Xanthomonas citri ssp. citri ; and wherein said genetically altered plant's resistance to said canker is greater than said wild-type plant's resistance to said canker; and wherein said optimized thionin comprises the amino acid sequence of SEQ ID NO: 14, said optimized pro-thionin comprises the amino acid sequence of SEQ ID NO: 6, said D4E1 comprises the amino acid sequence of SEQ ID NO: 2, and said pro-D4E1 comprises the amino acid of SEQ ID NO: 62.

7. The method of claim 6 , wherein said optimized thionin or said optimized pro-thionin is located at the amino terminus of said chimeric protein; and wherein said D4E1 is located at the carboxyl terminus of said chimeric protein.

8. The method of claim 6 , wherein said D4E1 or said pro-D4E1 is located at the amino terminus of said chimeric protein; and wherein said optimized thionin is located at the carboxyl terminus of said chimeric protein.

9. A genetically altered plant or part thereof produced by the method of claim 2 .

10. A genetically altered plant or part thereof produced by the method of claim 6 .

11. The method of claim 2 , wherein said linker comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 10, 39, 40, 41, and 42.

12. The method of claim 11 , wherein said chimeric protein comprises an amino acid sequence of SEQ ID NO: 8 or SEQ ID NO: 18.

13. A genetically altered plant or part thereof produced by the method of claim 12 .

14. The method of claim 6 , wherein said linker comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 10, 39, 40, 41, and 42.

15. The method of claim 14 , wherein said chimeric protein comprises an amino acid sequence of SEQ ID NO: 8 or SEQ ID NO: 18.

16. A genetically altered plant or part thereof produced by the method of claim 15 .

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2018
From: LOS ALAMOS NATIONAL SECURITY, LLC
To: TRIAD NATIONAL SECURITY, LLC
Reel/Frame 047485/0471 →
CONFIRMATORY LICENSE Recorded Nov 27, 2015
From: LOS ALAMOS NATIONAL SECURITY
To: U.S. DEPARTMENT OF ENERGY
Reel/Frame 037148/0980 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 13, 2015
From: GUPTA, GOUTAM
To: LOS ALAMOS NATIONAL SECURITY, LLC
Reel/Frame 036072/0746 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2015
From: STOVER, EDDIE W.; HAO, GUIXIA
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
Reel/Frame 035664/0570 →
Continuity (1)
Related Publication 20160312241A1 · Oct 27, 2016